Clinical Research Offers Hope
Avacare provides cutting-edge treatments to the patients of today, the patients of tomorrow, and those who love them. We manage clinical trials across many therapeutic specialties in over 40 geographic locations. Every trial is backed by rigorous scientific study and delivered by compassionate, experienced investigators focused on patient safety and satisfaction.
1/5
Asthma_ava
A Dose Finding Study With an Anti-TSLP Antibody (GSK5784283) in Adults Aged 18 to 75 Years of Age With Uncontrolled Asthma
This study is trying to find the right dose of a long-lasting medicine called GSK5784283 for people with asthma that remains uncontrolled even though they are using regular asthma treatments. GSK5784283 blocks the action of an inflammatory protein called TSLP that may be contributing to your asthma. The study will be conducted in two parts - Part A (dose finding phase) and Part B (extended dosing phase). Part A will assess the lung function, asthma control, participant safety and certain markers of asthma inflammation in the air you breath out and in your blood. Part B will assess the safety and long-term effects of the repeated or single doses of GSK5784283.
2/5
Vascular Disease
A Study to Evaluate VXA-CoV2-3.1 COVID-19 Vaccine Against Currently Approved/Authorized mRNA COVID-19 Injectable Booster Vaccine in Adults Previously Immunized Against COVID-19 Infection
The primary objective of the study is to determine the relative efficacy of the investigational oral severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) vaccine tablet VXA-CoV2-3.1 compared to a currently recommended vaccine for the prevention of symptomatic Coronavirus Disease 2019 (COVID-19).
3/5
Covid-19-vaccine
Vaccine clinical research studies now enrolling and seeking participants
Clinical research studies focused on a variety of vaccines are now enrolling. Complete the brief screening questionnaire to see if you quality.
4/5
Asthma_ava
A Dose Finding Study With an Anti-TSLP Antibody (GSK5784283) in Adults Aged 18 to 75 Years of Age With Uncontrolled Asthma
This study is trying to find the right dose of a long-lasting medicine called GSK5784283 for people with asthma that remains uncontrolled even though they are using regular asthma treatments. GSK5784283 blocks the action of an inflammatory protein called TSLP that may be contributing to your asthma. The study will be conducted in two parts - Part A (dose finding phase) and Part B (extended dosing phase). Part A will assess the lung function, asthma control, participant safety and certain markers of asthma inflammation in the air you breath out and in your blood. Part B will assess the safety and long-term effects of the repeated or single doses of GSK5784283.
5/5
Covid-19-vaccine
Vaccine clinical research studies now enrolling and seeking participants
Clinical research studies focused on a variety of vaccines are now enrolling. Complete the brief screening questionnaire to see if you quality.
Understand Clinical Research
Every new medication, treatment approach, preventive therapy, and medical device must undergo testing and evaluation before being approved for utilization as a standard of patient care. This is commonly known as the field of Clinical Research. Without the important work of clinical research professionals, the breakthrough findings of scientists would never translate into available treatments and quality of life benefits for patients.
Understand Clinical Research - Flexi
COVID-19
Let’s work together to find a way to prevent COVID-19
Help us find a way to speed up recovery from COVID-19 and reduce the need for hospital care.
Latest News
Alzheimer's Disease
How much do you know about Alzheimer's dementia?
Discover some common early symptoms and signs of Alzheimer's dementia Discover some common early symptoms and signs of Alzheimer's dementia Discover some common early symptoms and signs of Alzheimer's dementia
2023-01-30T18:30:00Z
Arthritis
How much do you know about Alzheimer's dementia?
Discover some common early symptoms and signs of Alzheimer's dementia
2023-03-14T18:30:00Z
Asthma_ava
How much do you know about Alzheimer's dementia?
Discover some common early symptoms and signs of Alzheimer's dementia
2023-03-14T18:30:00Z
Multiple Sclerosis (MS)
Stem cell research shows promise in treating relapsing-remitting multiple...
Pharmaceutical companies are rushing to fill the NASH treatment gap
2023-01-30T18:30:00Z
Nonalcoholic Steatohepatitis (NASH)
Making lifestyle changes: ten ideas to get started
Pharmaceutical companies are rushing to fill the NASH treatment gap
2023-03-14T18:30:00Z